An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression
scientific article
Author/s
author: Marjanka K Schmidt, Paolo Radice, Angela Cox, Mikael Hartman, Artitaya Lophatananon, Pascal Guénel, Kenneth Muir, Australian Ovarian Cancer Study Group, Børge G. Nordestgaard, Christine Ambrosone, Melissa C. Southey, Anna Jakubowska, Paul D P Pharoah, Sofia Khan, Anthony Swerdlow, Jan Lubiński, Julian Peto, Graham Giles, Per Hall, Diether Lambrechts, Alfons Meindl, Rita Schmutzler, Heli Nevanlinna, Susan L Neuhausen, Douglas F. Easton, Fergus J. Couch, Peter A. Fasching, John Hopper, Roger L. Milne, Ute Hamann, Annika Lindblom, Jacques Simard, Irene L Andrulis, Hermann Brenner, Daniel Klevebring, Wei Zheng, Jonine Figueroa, Matthias W. Beckmann, Sara Margolin, Stig Egil Bojesen, Isabel dos Santos Silva, Joe Dennis, Anja Rudolph, Javier Benitez, Amanda Ewart Toland, kConFab Investigators, Anna González-Neira, Christopher A. Haiman, Annegien Broeks, Brian E. Henderson, Elisa V. Bandera, David Van Den Berg, Xiao-Ou Shu, Yu-Tang Gao, Chen-Yang Shen, Daehee Kang, Ian Tomlinson, Suleeporn Sangrajrang, Maartje J. Hooning, Natalia V. Bogdanova, Elinor J. Sawyer, Julia A. Knight, Nick Orr, Janet E. Olson, Frederik Marmé, Anna H. Wu, Hidemi Ito, William J. Blot, Ans M W van den Ouweland, Manjeet K Bolla, Mitul Shah, Lisa B Signorello, Hatef Darabi, Hans Wildiers, GENICA Network, Soo Hwang Teo, Jirong Long, Tien Y Wong, Ji-Yeob Choi, Martine Dumont
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.